In the previous prospectus $5M was supposed to take AMD through in vivo proof of concept. Now, $4M is supposed to take AMD through in vivo proof of concept, IND and start of a clinical trial.
I know that being critical of management is not popular on HC but, come on, this is just finger in the wind budgeting and how can that be good management?